Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oseltamivir in high-risk patients with influenza
NCT02561169Phase 4Terminated
- Sponsor
- McMaster University
- Start
- Dec 2015
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of oseltamivir in influenza, sponsored by McMaster University. Primary endpoint: Non-elective Hospitalizations at 28 days. Started Dec 2015; status: terminated.
02
Drugs
oseltamivir
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02561169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02561169.